•  

Posts Tagged: University of Toronto

Globe and Mail and Global News Toronto cover early-stage Bio Printer technology

An early-stage technology that may revolutionize the way burn victims are treated is generating considerable buzz in Toronto media this week. Globe and Mail reporter Robert Everett-Green wrote about the joint University of Toronto and Sunnybrook Health Sciences Centre project January 20 in "A 3-D machine that prints skin? How burn care could be revolutionized." Health reporter Beatrice Politi also covered the Bio Printer project for Global News Toronto January 21. Her video segment includes an interview with PhD student Lian Leng and ... Read more

Shotlst: “Track changes” for the physical world

Shotlst is one of six inaugural UTEST companies; next UTEST application round to begin shortly What if you could turn on Microsoft Word’s “track changes” tool and apply it at will to the world around you? Sound like science fiction? Meet Matt Ratto, a professor in the University of T’s Faculty of Information, and Mike Borg, a recent graduate of the faculty. They’ve formed Shotlst, a new software company being incubated by the University of Toronto Early Stage Technology (UTEST) program. The central metaphor of ... Read more

MI Inventors Poon and Rahnama Pitch EMTech 2012 (Videos Online)

Being named to the MIT Technology Review's 35 Inventors Under 35 list is a prestigious honour, but one of its best perks is the subsequent invitation to attend the Emerging Technologies conference (EmTech). Joyce Poon and Hossein Rahnama, both researchers and inventors working with MaRS Innovation to license or spin-off technology projects, were named to the MIT Technology Review‘s prestigious 35 Inventors Under 35 list for 2012. They attended the EmTech 2012 from October 24 to 26 where they each made a three-minute ... Read more

Gen Magazine features Dr. Aaron Wheeler’s research in microfluidics

GEN Magazine (Genetic Engineering and Biotechnology News) featured the microfluidics research of Dr. Aaron Wheeler on November 15, 2012. Wheeler, Canada Research Chair of Bioanalytical Chemistry and an associate professor at the University of Toronto, has made an invention disclosure to MaRS Innovation; Kapplex is the start-up company created to commercialize his research. (more…) Read more

Stem Cell Therapeutics, UHN and MaRS Innovation Announce Novel, Clinical-Stage, Cancer Stem Cell Program Agreement

Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a life sciences company developing stem cell-related technologies, today announced the signing of an agreement with University Health Network (UHN), through its commercialization agent MaRS Innovation (MI), both of Toronto. The agreement provides Stem Cell Therapeutics ("SCT") with an option to an exclusive world-wide license to an innovative cancer stem cell program. This agreement produced a license for a UHN technology on April 17, 2013. (more…) Read more

Shotlst CEO featured in Globe article on future of tech in education

Matt Ratto, assistant professor in the University of Toronto's Faculty of Information and co-inventor and CEO of Shotlst, a UTEST company, was featured in the Globe and Mail on October 22 in an article by Nick Rockel on how emerging technology will change the education experience. Here's an excerpt: Asked what the technological tools in university classrooms will look and feel like by 2020, Matt Ratto admits he’s no futurist. But the assistant professor at the University of Toronto’s Faculty of Information is ... Read more

Baxter and MaRS Innovation Form Strategic Partnership

Partnership to invest up to $1M in promising Canadian healthcare discoveries TORONTO, Ontario, October 4, 2012—Baxter International Inc. and MaRS Innovation, a Centre of Excellence for Commercialization and Research, have entered into a strategic partnership to commercialize early-stage technologies that present innovative methods in therapeutics and drug discovery technologies. Information about Baxter and MaRS Innovation's partnership is also available in French. The partnership’s shared vision for delivering novel, transformative therapeutic technologies will benefit Canadians and others around the world. Baxter and MaRS Innovation will ... Read more

U of T, MaRS Innovation Collaborate to Launch Incubator for Student Software Companies

TORONTO, ON – A new program that provides nascent software companies with start-up funds, work space, mentoring and business strategy support, was launched today by the University of Toronto and commercialization partner MaRS Innovation, with support from the MaRS Discovery District. TechVibes has a profile page for UTEST and covered CoursePeer as part of their students start-ups series. The new program, called University of Toronto Early Stage Technology (UTEST), is part of a growing ecosystem of incubators and commercialization support services at U ... Read more

Business Without Borders highlights ScarX Therapeutics’ Chinese co-development partnership

ScarX Therapeutics, a spin-off company created by MaRS Innovation and The Hospital for Sick Children (SickKids), was profiled by Business Without Borders on September 25, 2012. Sean Fine's article examines the strategic funding partnership MI pursued with NovoTek Therapeutics Inc. (NovoTek) in China to develop the anti-scarring cream, which was discovered by researchers at SickKids. A multibillion-dollar market may await ScarX, a Toronto biomedical start-up, but first it had to figure out how to finance the development of its unique cream that reduces scarring ... Read more

BioCentury features Encycle Therapeutics and MaRS Innovation in macrocycle chemistry article

Encycle Therapeutics, a MaRS Innovation spin-off company, was included in BioCentury's companies to watch within the macrocycle chemistry space. The reference came in Chris Cain's article, "Maturing macrocycle chemistry drives explosion of biotech newcos, biopharma deals." (more…) Read more
Page 10 of 12« First...89101112